Attend the FierceBiotech Drug Development Forum
The leading executive-level forum for biotech strategy & networking | Oct 28-29 | Boston
Following an FBI raid and the replacement of its leadership, it’s come to light that the data behind uBiome’s microbiome test may contain flaws.
The National Institutes of Health has tapped the genomics firm Color to help participants understand and act on their results.
In a $72 million deal, Inex Innovations Exchange and Nova Satra will combine their laboratory, R&D and distribution arms.
Encellin is working on a cell pouch that cuts down on the scarring that comes with encapsulated cell transplants.
Medtronic aims to boost its growth with a suite of new products including surgical robotics, diabetes hardware and miniaturized pacemakers.
Boston Scientific’s deep brain stimulation implant for treating Parkinson’s disease has been approved by the FDA as safe to use within an MRI.
The FDA approved a new device for people suffering from advanced heart failure who are not able to receive treatment from other devices.
Alcon has announced plans to launch its daily disposable contact lens in the U.S. made from a new material.
A mesh of integrated, electric sensors aims to track the earliest stages of tissue development and differentiation.
The FDA broadened its approvals of several transcatheter aortic valve replacements to include patients at a low risk of surgical complications.